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Background: ICDs are placed in patients at risk for sudden cardiac death as standard of care, but complications of the implantation procedure 
remain an important public health problem. Patient body habitus may be an important factor responsible for complications of ICD implantation 
procedures. We sought to determine whether underweight or obese patients compared to normal weight patients, as defined by body mass index 
(BMI), were at increased risk for adverse events from ICD implantation in a large, real-world population.
Methods: This was a retrospective cohort study of 83,312 cases submitted to the NCDR-ICD Registry between April 1, 2010 and September 30, 
2011. Using multivariate hierarchical logistic regression adjusting for patient demographic and clinical characteristics, we examined the association 
of BMI with in-hospital complications, mortality and length of stay in patients receiving ICDs.
Results: Underweight (BMI ≤18.5 kg/m2) patients comprised 1.7% of the cohort (n=1,434) whereas obese (BMI ≥30 kg/m2) patients 
comprised 40.1% (n=33,339). In-hospital mortality and complications were more common in underweight patients compared to normal weight 
patients (18.5 kg/m2 < BMI < 30 kg/m2). Eleven (0.8%) underweight patients versus 166 (0.3%) normal weight patients died (p=0.026) and 74 
(5.2%) underweight patients versus 1,100 (2.3%) normal weight patients experienced a complication (p<0.001). After multivariable adjustment, 
underweight individuals had a 2.1 fold greater odds of death (95% CI1.09-4.06; p=0.026) and a 2.1 fold greater odds of a complication (95% 
CI1.65-2.73; p<0.001). Underweight patients also experienced longer hospital stays, exhibiting a 1.6 fold greater odds of staying in the hospital 
more than 3 days after implant (95% CI1.39-1.91; p<0.0001) compared to normal weight patients. Overweight patients did not exhibit any 
meaningful differences in complications, mortality or length of stay compared to normal weight patients.
Conclusions: In a large, real-world population, underweight ICD recipients experienced significantly more in-hospital mortality, periprocedural 
complications and longer hospital stays compared to normal weight patients.
